Concepedia

M. Kudo

MK

Statistics

Publications

1

Citations

85

H-Index

1

Active since

2024

Affiliations

National Taiwan University Hospital(Current)

M. Kudo is an author at National Taiwan University Hospital specializing in hepatocellular carcinoma pharmacotherapy, atezolizumab therapy, and oncology.

Publications per year

2024–2024

1

Publications

1

LBA39 Updated efficacy and safety data from IMbrave050: Phase III study of adjuvant atezolizumab (atezo) + bevacizumab (bev) vs active surveillance in patients (pts) with resected or ablated high-risk hepatocellular carcinoma (HCC)

Adam C. Yopp, M. Kudo, Mingkai Chen et al. · Annals of Oncology · 2024 · 85 citations · Full text

, , +15

1–1 of 1